TrademarkDir
FOUNDATIONINSIGHTS
LIVE

Serial Number

87521776

Owner

Foundation Medicine, Inc.

Attorney

Douglas R. Wolf

Filing Date

Jul 10, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

FOUNDATIONINSIGHTS Trademark

Serial Number: 87521776 • Registration: 5527892

FOUNDATIONINSIGHTS is a trademark filed by Foundation Medicine, Inc. on July 10, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Foundation Medicine, Inc. (54 trademarks)

One Kendall Square, Suite B6501
Cambridge, MA 02139

Entity Type: 03

Trademark Details

Filing Date

July 10, 2017

Registration Date

July 31, 2018

Published for Opposition

May 15, 2018

Goods & Services

providing online genomic, genetic, and molecular medical information for cancer diagnostic or treatment purposes; providing analyzed medical information in the field of cancer genomics for cancer for diagnostic and treatment purposes; providing medical data and information to healthcare professionals and researchers

providing an online non-downloadable, Internet-based software application featuring medical, genetic, and genomic information and data in the field of cancer; providing an online non-downloadable, Internet-based software application for analyzed medical information in the field of cancer genomics for cancer for medical purposes

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 18, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 18, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 18, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 17, 2024 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2024 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 31, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 28, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 28, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2022 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 2, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 2, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 2, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 2, 2021 COAR
REGISTERED-PRINCIPAL REGISTER
Jul 31, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 15, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 15, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 25, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2018 CRFA
ASSIGNED TO LIE
Mar 20, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 7, 2017 GNRN
NON-FINAL ACTION E-MAILED
Sep 7, 2017 GNRT
NON-FINAL ACTION WRITTEN
Sep 7, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 31, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 15, 2017 NWOS

Related Trademarks

More from this Owner

FOUNDATIONMARKERS

FOUNDATIONMARKERS

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE GERMLINE MORE

FOUNDATIONONE PGX

FOUNDATIONONE PGX

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.

CANCER BRINGS UNCERTAINTY. GENOMIC TESTING BRINGS ANSWERS.